Arena Pharma describes new potent and selective lysophospholipid S1P1 receptor agonists April 11, 2011
Novel PLK4 inhibitors demonstrate antiproliferative activity in models of breast cancer April 11, 2011
Antitumor activity of TAK-441 involves inhibition of zinc finger protein GLI1 expression April 8, 2011
Multiple studies of hepatitis C treatment telaprevir presented at International Liver Congress April 8, 2011
AXL-1717 exhibits safety/tolerability in subjects with advanced tumors in phase I/II trial April 8, 2011
New farnesoid X receptor agonist Px-20606 prevents nonalcoholic steatohepatitis in an animal model April 8, 2011
RSS